Connect Biopharma Holdings Limited
CNTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,628 | -$59,383 | -$116,118 | -$204,939 |
| Dep. & Amort. | $660 | $988 | $1,014 | $641 |
| Deferred Tax | $0 | $0 | $3,365 | $106,368 |
| Stock-Based Comp. | $6,728 | $3,259 | $1,009 | $1,411 |
| Change in WC | -$15,490 | $9,485 | $7,160 | $3,269 |
| Other Non-Cash | $118 | -$2,279 | -$1,351 | $7 |
| Operating Cash Flow | -$23,612 | -$47,930 | -$99,270 | -$85,568 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$750 | -$294 | -$4,282 | -$7,463 |
| Net Acquisitions | $0 | $2,943 | $79 | $48 |
| Inv. Purchases | -$15,451 | -$32,601 | -$113,704 | -$17,979 |
| Inv. Sales/Matur. | $12,627 | $105,191 | $34,543 | $20,100 |
| Other Inv. Act. | $123 | -$84 | -$79 | -$48 |
| Investing Cash Flow | -$3,451 | $75,155 | -$83,444 | -$5,343 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$290 | -$222 | -$126 |
| Stock Issued | $227 | $44 | $18 | $219,985 |
| Stock Repurch. | $0 | $0 | $0 | -$566 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $119 | -$17,073 |
| Financing Cash Flow | $227 | -$246 | -$91 | $206,662 |
| Forex Effect | -$595 | $18 | $13,875 | -$6,335 |
| Net Chg. in Cash | -$27,431 | $26,997 | -$168,930 | $109,416 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $105,663 | $79,010 | $249,301 | $158,608 |
| End Cash | $78,232 | $106,007 | $80,371 | $268,025 |
| Free Cash Flow | -$24,362 | -$48,224 | -$103,552 | -$93,031 |